Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Emerging treatment options for extraintestinal manifestations in IBD.
Identification of the Novel Tooth-Specific Transcription Factor AmeloD.
Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging treatment options for extraintestinal manifestations in IBD.
Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2021 04; 70(4):796-802.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Biological Therapy
Humans
Inflammatory Bowel Diseases
Tumor Necrosis Factor-alpha
authors with profiles
David T. Rubin